Recombinant adeno-associated virus (rAAV) is a key vector in delivering therapeutic genes for genetic disorders. To optimize clinical efficacy, the ratio of ‘full’ to ’empty’ viral particles must be balanced. Mass photometry revolutionizes this process by precisely measuring and analyzing these particles, ensuring a more effective gene therapy production workflow. With this advancement, researchers can […]